Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Anergen Inc.

Division of GlaxoSmithKline PLC

Latest From Anergen Inc.

Peptimmune Inc.

By intervening at the level of antigen processing and presentation, Peptimmune aims to develop drugs that downregulate the inappropriate immune response that occurs in such autoimmune disorders as multiple sclerosis and rheumatoid arthritis and to boost the response in the case of HIV and other viruses.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Barry M Sherman, MD, Pres. & CEO
    David V Smith, VP, Fin. & CFO
    Thadd Vargas, Mgr., Bus. Dev.
    Maureen Howard, PhD, VP, R&D
  • Contact Info
  • Anergen Inc.
    Phone: (415) 361-8901
    301 Penobscot Dr.
    Redwood City, CA 94063